Encompass Health (EHC) Competitors

$86.20
-0.33 (-0.38%)
(As of 05/13/2024 ET)

EHC vs. SEM, VKTX, CHE, LEGN, HSIC, PEN, ROIV, BIO.B, BIO, and RGEN

Should you be buying Encompass Health stock or one of its competitors? The main competitors of Encompass Health include Select Medical (SEM), Viking Therapeutics (VKTX), Chemed (CHE), Legend Biotech (LEGN), Henry Schein (HSIC), Penumbra (PEN), Roivant Sciences (ROIV), Bio-Rad Laboratories (BIO.B), Bio-Rad Laboratories (BIO), and Repligen (RGEN). These companies are all part of the "medical" sector.

Encompass Health vs.

Select Medical (NYSE:SEM) and Encompass Health (NYSE:EHC) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

Encompass Health has a net margin of 7.60% compared to Encompass Health's net margin of 3.97%. Encompass Health's return on equity of 18.11% beat Select Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Select Medical3.97% 18.11% 3.64%
Encompass Health 7.60%18.01%6.55%

Encompass Health received 159 more outperform votes than Select Medical when rated by MarketBeat users. Likewise, 71.83% of users gave Encompass Health an outperform vote while only 57.85% of users gave Select Medical an outperform vote.

CompanyUnderperformOutperform
Select MedicalOutperform Votes
328
57.85%
Underperform Votes
239
42.15%
Encompass HealthOutperform Votes
487
71.83%
Underperform Votes
191
28.17%

Select Medical pays an annual dividend of $0.50 per share and has a dividend yield of 1.5%. Encompass Health pays an annual dividend of $0.60 per share and has a dividend yield of 0.7%. Select Medical pays out 23.8% of its earnings in the form of a dividend. Encompass Health pays out 16.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

In the previous week, Encompass Health had 16 more articles in the media than Select Medical. MarketBeat recorded 23 mentions for Encompass Health and 7 mentions for Select Medical. Encompass Health's average media sentiment score of 1.04 beat Select Medical's score of 0.62 indicating that Select Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Select Medical
2 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Encompass Health
7 Very Positive mention(s)
5 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

89.5% of Select Medical shares are owned by institutional investors. Comparatively, 97.3% of Encompass Health shares are owned by institutional investors. 17.5% of Select Medical shares are owned by company insiders. Comparatively, 2.1% of Encompass Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Encompass Health has lower revenue, but higher earnings than Select Medical. Select Medical is trading at a lower price-to-earnings ratio than Encompass Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Select Medical$6.66B0.65$243.49M$2.1015.87
Encompass Health$4.80B1.80$352M$3.7023.26

Select Medical has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. Comparatively, Encompass Health has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500.

Select Medical presently has a consensus target price of $34.25, suggesting a potential upside of 2.76%. Encompass Health has a consensus target price of $90.29, suggesting a potential upside of 4.90%. Given Select Medical's stronger consensus rating and higher possible upside, analysts plainly believe Encompass Health is more favorable than Select Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Select Medical
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Encompass Health
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13

Summary

Encompass Health beats Select Medical on 15 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EHC vs. The Competition

MetricEncompass HealthHospitals IndustryMedical SectorNYSE Exchange
Market Cap$8.66B$4.57B$4.86B$17.82B
Dividend Yield0.69%1.09%38.86%3.47%
P/E Ratio23.2613.13125.8622.55
Price / Sales1.800.942,404.4010.39
Price / Cash13.299.2632.0815.76
Price / Book3.822.474.944.97
Net Income$352M$178.36M$101.44M$963.48M
7 Day Performance1.85%-1.28%2.14%1.80%
1 Month Performance6.92%5.60%1.93%3.96%
1 Year Performance40.39%6.35%7.80%133.04%

Encompass Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SEM
Select Medical
4.8557 of 5 stars
$32.74
+2.0%
$34.80
+6.3%
+18.9%$4.26B$6.66B15.5954,600Positive News
VKTX
Viking Therapeutics
4.4941 of 5 stars
$79.61
+1.8%
$112.25
+41.0%
+226.9%$8.78BN/A-85.6028
CHE
Chemed
4.9721 of 5 stars
$580.70
+1.7%
$681.00
+17.3%
+5.1%$8.79B$2.26B31.2515,087Short Interest ↓
Positive News
LEGN
Legend Biotech
2.1907 of 5 stars
$45.99
+1.6%
$82.64
+79.7%
-38.5%$8.37B$285.14M-31.071,800Short Interest ↑
News Coverage
Gap Up
HSIC
Henry Schein
4.4782 of 5 stars
$71.20
+3.9%
$81.09
+13.9%
-4.1%$9.15B$12.34B22.6025,000Earnings Report
Analyst Revision
PEN
Penumbra
4.8222 of 5 stars
$210.00
-0.8%
$304.45
+45.0%
-33.8%$8.14B$1.06B90.914,200Earnings Report
ROIV
Roivant Sciences
3.4081 of 5 stars
$11.38
-1.9%
$16.90
+48.5%
+22.2%$9.17B$123.24M2.19904Positive News
BIO.B
Bio-Rad Laboratories
0 of 5 stars
$279.91
flat
N/A-25.1%$7.98B$2.67B-13.037,900Gap Down
BIO
Bio-Rad Laboratories
4.6466 of 5 stars
$279.91
-0.7%
$468.00
+67.2%
-24.3%$7.98B$2.67B-13.038,030Earnings Report
Short Interest ↑
RGEN
Repligen
4.2178 of 5 stars
$167.72
-0.2%
$197.75
+17.9%
+9.8%$9.37B$638.76M670.911,783Positive News

Related Companies and Tools

This page (NYSE:EHC) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners